ABVD vs. radiotherapy in early stage Hodgkin's lymphoma A critical look at the NCIC HD.6 trial

被引：0
|
作者：
Wenz, F. [1 ]
Abo-Madyan, Y. [1 ]
Welzel, G. [1 ]
Giordano, F. A. [1 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr Mannheim, D-68167 Mannheim, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2012年 / 188卷 / 08期
关键词：
2ND MALIGNANCIES; DISEASE; CANCER; RADIATION; CHEMOTHERAPY; THERAPY; INTENSITY; NEOPLASMS; LEUKEMIA; COHORT;
D O I：
10.1007/s00066-012-0151-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：649 / 652
页数：4
相关论文
共 50 条
  • [31] Do we need consolidative Radiotherapy in the treatment of early stage Hodgkin's Lymphoma?
    Eich, H. T.
    Kriz, J.
    ONKOLOGIE, 2013, 36 : 90 - 90
  • [32] Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma
    Harris, MA
    Radford, JA
    Deakin, DP
    James, RD
    Swindell, R
    Cowan, RA
    CLINICAL ONCOLOGY, 2004, 16 (01) : 53 - 57
  • [33] RETROSPECTIVE ANALYSIS OF EARLY STAGE HODGKIN'S LYMPHOMA TREATED WITH CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY
    Giordano, A.
    Gaudio, F.
    Perrone, T.
    De Risi, C.
    Spina, A.
    Curci, P.
    Miccolis, R.
    Scardino, S.
    Sorino, M.
    Colonna, P.
    Pedote, P.
    Specchia, G.
    Liso, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 634 - 634
  • [34] The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma
    Jorgensen, Anni Y. S.
    Maraldo, Maja V.
    Brodin, Nils Patrik
    Aznar, Marianne C.
    Vogelius, Ivan R.
    Rosenschold, Per Munck A. F.
    Petersen, Peter M.
    Specht, Lena
    ACTA ONCOLOGICA, 2013, 52 (07) : 1559 - 1565
  • [35] Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy
    Simontacchi, Gabriele
    Filippi, Andrea Riccardo
    Ciammella, Patrizia
    Buglione, Michela
    Saieva, Calogero
    Magrini, Stefano Maria
    Livi, Lorenzo
    Iotti, Cinzia
    Botto, Barbara
    Vaggelli, Luca
    Re, Alessandro
    Merli, Francesco
    Ricardi, Umberto
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (05): : 1077 - 1083
  • [36] Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy
    Adams, Hugo J. A.
    Kwee, Thomas C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : 724 - 725
  • [37] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's lymphoma
    Eich, HT
    Müller, RP
    Engert, A
    Wolf, J
    Hansemann, K
    Pfistner, B
    Diehl, V
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 56 - 56
  • [38] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
    Mueller, R. P.
    Eich, H. T.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilbom, K.
    Eble, M.
    Mueller-Hennelink, H.
    Diehl, V.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S27
  • [39] Dacarbazine is an essential component of ABVD in the treatment of early favourable Hodgkin Lymphoma: Results of the second interim analysis of the GHSG HD13 trial
    Borchmann, P.
    Topp, M. S.
    Behringer, K.
    Boell, B.
    Diehl, V
    Lohri, A.
    Fuchs, M.
    Eich, H. T.
    Engert, A.
    ONKOLOGIE, 2010, 33 : 124 - 125
  • [40] DACARBAZINE IS AN ESSENTIAL COMPONENT OF ABVD IN THE TREATMENT OF EARLY FAVOURABLE HODGKIN LYMPHOMA: RESULTS OF THE SECOND INTERIM ANALYSIS OF THE GHSG HD13 TRIAL
    Borchmann, P.
    Diehl, V.
    Goergen, H.
    Lohri, A.
    Zilstra, J.
    Topp, M.
    Fuchs, M.
    Eich, H.
    Engert, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 473
12345